Roles of paraoxonase and oxidative stress in adolescents with uraemic, essential or obesity-induced hypertension

Kidney and Blood Pressure Research

Volumn 29, Issue 3, 2006, Pages 144-151

  Baráth, Ákos ^a,b   Németh, Ilona ^a   Karg, Eszter ^a   Endreffy, Emoke ^a   Bereczki, Csaba ^a   Gellén, Balázs ^a   Haszon, Ibolya ^a   Túri, Sándor ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Adolescents; Essential hypertension; Haemodialysis; Oxidative stress; Paraoxonase

Indexed keywords

ARGININE; ARYLDIALKYLPHOSPHATASE 1; CYSTEINE; GLUTAMINE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LIPID; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; NITRIC OXIDE;

ADOLESCENT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HEMODIALYSIS; HUMAN; HYDROLYSIS; HYPERTENSION; LIPID HYDROLYSIS; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UREMIA;

ADOLESCENT; ANALYSIS OF VARIANCE; ARYLDIALKYLPHOSPHATASE; FEMALE; GLUTATHIONE; HOMOCYSTEINE; HUMANS; HYPERTENSION; LIPID PEROXIDES; MALE; OBESITY; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; RENAL DIALYSIS; UREMIA;

EID: 33750190451     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095124     Document Type: Article

References (36)

1. Drexler H, Hornig B: Endothelial dysfunction in human disease. J Mol Cell Cardiol 1999;31:51-60.
2. Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000;87:840-844.
3. Turi S, Friedman A, Bereczki C, Papp F, Kovacs J, Karg E, Nemeth I: Oxidative stress in juvenile essential hypertension. J Hypertens 2003;21:145-152.
4. Blatter M-C, James RW, Messmer S, Barja F, Pometta D: Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem 1993;211:871-879.
5. Mackness MI, Arrol S, Durrington PN: Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 1991;286:152-154.
6. Mackness MI, Arrol S, Abbot C, Durrington PN: Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 1993;104:129-135.
7. Shih DM, Gu L, Xia Y-R, Navab M, Li W-F, Hama S, Castellani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ: Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998;394:284-287.
8. Primo-Parmo SL, Hsu C, Law DJ, La Du BN: Location and arrangement of three paraoxonase genes: PON1, PON2, and PON3, on human chromosome 7. Am J Hum Genet 1996;59 (suppl):A406.
9. Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE: The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 1993;3:73-76.
10. Clendenning, JB, Humbert R, Green ED, Wood C, Traver D, Furlong CE: Structural organization of the human PON1 gene. Genomics 1996;35:586-589.
11. Adkins S, Gan KN, Mody M, La Du BN: Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B alloenzymes. Am J Hum Genet 1993;52:598-608.
12. Ito T, Yasue H, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, Harada E, Mizuno Y, Kawano H, Ogawa H: Paraoxonase gene gln192-to-arg (Q192R) polymorphism is associated with coronary artery spasm. Hum Genet 2002;110:89-94.
13. Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN: Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 1998:423:57-60.
14. Soergel M, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R, Krull F, Reichert H, Reusz GS, Rascher W: Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 1997;130:178-184.
15. Brewer ED, Avner ED, Harmon WE, Niaudet P: Evaluation of hypertension in childhood diseases. Pediatric Nephrology ed 5. Lippincott, Williams and Wilkins, Philadelphia, 2004, pp 1179-1197.
16. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
17. Pocsai Zs, Tóth Zs, Paragh Gy, Szeles G, Adany R: Rapid genotyping of paraoxonase 55 and 192 mutations by melting point analysis using real time PCR technology. Clinica Chimica Acta 2003;332:31-36.
18. Eckerson HW, Romson J, Wyte C, La Du BN: The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am J Hum Genet 1983;35:214-227.
19. Dantoine TF, Debord J, Charmes JP, Merle L, Marquet P, Lachatre G, Leroux-Robert C: Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol 1998;9:2082-2088.
20. Marzinzig M, Nussler AK, Stadler J, MarzinzigE, Barthlen W, Nussler NC, Beger HG, Morris SM Jr, Bruckner UB: Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiols. Nitric Oxide 1997;1:177-189.
21. Wong SHY, Knight JA, Hopfer SM, Zaharia O, Leach CN Jr, Sunderman FW Jr: Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 1987;33:214-220.
22. Nemeth I, Boda D: Blood glutathione redox ratio as a parameter of oxidative stress in premature infants with IRDS. Free Radic Biol Med 1994;16:347-353.
23. Tietze F: Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969;27:502-522.
24. Gilfix BM, Blank DW, Rosenblatt DS: Novel reductant for determination of total plasma homocysteine. Clin Chem 1997;43:687-688.
25. Kuo K, Still R, Cale S, McDowell I: Standardization (external and internal) of HPLC assay for plasma homocysteine. Clin Chem 1997;43:1653-1655.
26. Mackness B, Davies GK, Turkie W, Lee E, Roberts DH, Hill E, Roberts C, Durrington PN, Mackness MI: Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol 2001;21:1451-1457.
27. Serrato M, Marian AJ: A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J Clin Invest 1995;96:3005-3008.
28. Ruiz J, Blanche H, James RW, Garin MC, Vaisse C, Charpentier G, Cohen N, Morabia A, Passa P, Froguel P: Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 1995;346:869-872.
29. Jung HH, Choi DH, Lee SH: Serum malondialdehyde and coronary artery disease in hemodialysis patients. Am J Nephrol 2004;24:537-542.
30. Jakubowski H: Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation. J Biol Chem 2000;275:3957-3962.
31. Jakubowski H, Zhang L, Bardeguez A, Aviv A: Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis. Circ Res 2000;87:45-51.
32. Kedziora-Kornatowska K, Czuczejko J, Pawluk H, Kornatowski T, Motyl J, Szadujkis-Szadurski L, Szewczyk-Golec K, Kedziora J: The markers of oxidative stress and activity of the antioxidant system in the blood of elderly patients with essential arterial hypertension. Cell Mol Biol Lett 2004;9:635-641.
33. Dickinson DA, Forman HJ: Cellular glutathione and thiol metabolism. Biochem Pharmacol 2002;64:1019-1026.
34. Costagliola C, Romano L, Sorice P, Di Benedetto A: Anemia and chronic renal failure: the possible role of the oxidative state of glutathione. Nephron 1989;52:11-14.
35. Canestrari F, Buoncristiani U, Galli F, Giorgini A, Albertini MC, Carobi C, Pascucci M, Bossu M: Redox state, antioxidative activity and lipid peroxidation in erythrocytes and plasma of chronic ambulatory peritoneal dialysis patients. Clin Chim Acta 1995;31:127-136.
36. Biasioli S, Schiavon R, De Fanti E, Cavalcanti G, Giavarina D: The role of erythrocytes in the deperoxidative processes in people on hemodialysis. ASAIO J 1996;42:890-894.